ArticleBMC public health2026
A quasi-experimental study evaluating the effectiveness of a male-specific tuberculosis screening and diagnosis intervention in Uganda (IGNITE).
Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDespite men having a higher burden of TB, they are frequently missed by TB services due to social, behavioural, and health system factors that limit healthcare access. In Uganda, where there are no gender-specific guidelines for TB, we implemented and evaluated a gender-specific intervention to find and treat men with TB.
methodsWe conducted a quasi-experimental study comparing TB notifications before (January-June 2023) and after (July-December 2023) the intervention at both intervention (Gombe and Mityana hospitals) and control (Luwero and Kiboga hospitals) sites. The intervention package aimed to enhance TB screening documentation by using checklist stamps, distribute TB educational materials, and introduce male-friendly TB clinics with evening opening hours, health education delivered by male champions, and integrated screening for TB, HIV, diabetes, and hypertension. We extracted data from TB registers and fitted a quasi-Poisson regression model, adjusting for catchment population dynamics by gender, to assess the intervention's effects on TB case notification rates.
resultsOverall, 6,415 people in the participating hospitals were presumed to have TB, and 53.3% of these were females. Post-intervention, TB notifications increased by 46.3% (Female 0%, Male 88.4%) in Gombe and 36.4% (Female 26.3%, Male 45.1%) in Mityana; while they reduced by 26.7% (Female 28.8%, Male 25.5%) in Luwero and by 15.4% (Female + 23.9%, Male - 31.8%) in Kiboga. The baseline case notification rate was 246/100,000 population. Post-intervention analysis demonstrated that the intervention significantly increased TB case notification rates (RR: 1.51, 95% CI: 1.03-2.22), and males had a higher notification rate than females (RR: 1.5, 95% CI: 1.23-1.83). The treatment initiation rates pre- and post-intervention ranged between 97.4% and 100% in women, and 91.4% to 97.7% in men.
conclusionsGender-specific interventions for screening people with TB and linking them to care can be mutually beneficial at improving notifications among men and women.
trial registrationThe trial was registered retrospectively on the Pan African Clinical Trial Registry (PACTR202509682831484) on 29th September 2025.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.